With a range of heavy-hitting speakers, including former President Barack Obama, attendees gathered at the Brooklyn Navy Yard to learn more about the possibilities of the future of healthcare and biomedicine, and reflect on lessons learned from the past.
If you are not happy with the results below please do another search
50 search results for:
HBA’s Advancement. Commitment. Engagement. (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. The awards will be presented on Thursday, 3 November, in conjunction with HBA’s Annual Conference in Philadelphia.
The U.S. Food and Drug Administration said on Tuesday it will now review only a small number of emergency use authorization requests for COVID tests that are likely to have a significant benefit to public health, including fulfilling an unmet need.
The U.S. Equal Employment Opportunity Commission filed a lawsuit Monday against Eli Lilly and Co. alleging the company refused to hire older workers for sales representative positions.
Sanofi has inked a licensing deal with Scribe Therapeutics to develop novel natural killer (NK) cell therapies for cancer using Scribe’s CRISPR genome editing technology.
Nemaura and EVERSANA will work together to develop the optimal launch strategy for large-scale adoption of the diabetes management program, including franchising and direct sales to self-insured corporate clients and healthcare insurers.
Japan’s population level immunity to COVID-19 has reached about 90% in major population areas after a recent Omicron wave, though that level of protection is likely to diminish in a matter of months, according to a study published on Tuesday.
The agency put the partial hold after a serious adverse event was seen in a patient during the study.
The lawsuit accused Biogen of directing millions of dollars in kickbacks to doctors to prescribe its MS drugs Avonex, Tysabri and Tecfidera from 2009 to 2014, with kickbacks delivered in the form of “sham” consulting deals and speaker programs as well as lavish dinners and entertainment.
The agency had earlier said Moderna requested authorization for additional batches in light of the current supply issues. It did not provide details on the number of doses cleared.